'Intravenous immunoglobulin' presentation slideshows

William Tarnow-Mordi Professor of Neonatal Medicine University of Sydney

1.49k views • 133 slides

IMMUNODEFICIENCY

IMMUNODEFICIENCY. LANGE CHAPTER 68 DR SAMUEL AGUAZIM. Immunodeficiency can occur in any of the four major components of the immune system 1. B-cells 2. T- cells 3. Complement 4. Phagocytes Note: recurrent infection or opportunistic infections are commonly seen. B cell Deficiencies.

945 views • 53 slides

DoH IVIG Workshop Update on usage in Transplantation and outcomes measurement

459 views • 30 slides

Grand Rounds

374 views • 26 slides

BLOOD THERAPY

BLOOD THERAPY. BLOOD PRODUCTS(1). Blood-cells products whole blood packed red blood cells leukocyte-poor (reduced) red cells washed red blood cells random-donor platelets concentrates single-donor platelets concentrates [human leukocyte antigens(HLA)-matched platelets]

588 views • 21 slides

Global Intravenous Immunoglobulin Market Forecast 2014-2021

IVIG is a sterile solution of antibodies collected from healthy donors, which is administered through the veins into the body. Currently, the immunoglobulin industry is growing on account of increasing FDA/EMA approvals and government support. IVIG usage against the conditions within the criteria (i.e. FDA/EMA approved indications) have increased greatly and the largest increase found in Chronic Inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia and immunodeficiency diseases.

365 views • 11 slides

Intravenous Immunoglobulin (IVIg)

Design of modified immunoglobuin preparations with induced polyspecificity for passive immunotherapy of sepsis Dozent Stephan von Gunten Institute of Pharmacology, University of Bern and Prof. Tchavdar Vassilev Stephan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia.

126 views • 10 slides

Intravenous Immunoglobulin Market Research Report by Geographical Analysis and Forecast to 2024

According to the research report, the market will exhibit a healthy 8.5% CAGR over the period between 2016 and 2024. Expanding at this pace, the market, which valued at US$7.23 billion in 2015, is expected to reach US$14.92 billion in 2024.

72 views • 4 slides